BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Afaloniati H, Angelopoulou K, Giakoustidis A, Hardas A, Pseftogas A, Makedou K, Gargavanis A, Goulopoulos T, Iliadis S, Papadopoulos V, Papalois A, Mosialos G, Poutahidis T, Giakoustidis D. HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice. Onco Targets Ther 2020;13:5575-88. [PMID: 32606772 DOI: 10.2147/OTT.S250233] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Zhong F, Li J, Yue H, Li W, Lu X. The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer. J Transl Med 2023;21:38. [PMID: 36681835 DOI: 10.1186/s12967-022-03854-1] [Reference Citation Analysis]
2 Chen H, Xie C, Chen Q, Zhuang S. HDAC11, an emerging therapeutic target for metabolic disorders. Front Endocrinol 2022;13:989305. [DOI: 10.3389/fendo.2022.989305] [Reference Citation Analysis]
3 Zhu W, Zhang X, Yu M, Zhang Y, Li S, Yu C, Muhammad N. Profiles of Acetylation Regulation Genes Contribute to Malignant Progression and Have a Clinical Prognostic Impact on Liver Cancer. Disease Markers 2022;2022:1-19. [DOI: 10.1155/2022/1724301] [Reference Citation Analysis]
4 Xia J, Qin X, Zhang L, Liu S, Shi X, Ren H. Roles and regulation of histone acetylation in hepatocellular carcinoma. Front Genet 2022;13:982222. [DOI: 10.3389/fgene.2022.982222] [Reference Citation Analysis]
5 Li J, Zhang ZC, Yuan XS, Tang SS, Wang T, Liu HF, Cao Y. TOPK Affects Autophagy of Skin Squamous Cell Carcinoma by Regulating NF-KB Pathway through HDAC1. Dis Markers 2022;2022:3771711. [PMID: 35756488 DOI: 10.1155/2022/3771711] [Reference Citation Analysis]
6 Sunil AA, Skaria T. Novel regulators of airway epithelial barrier function during inflammation: potential targets for drug repurposing. Expert Opin Ther Targets 2022. [PMID: 35085478 DOI: 10.1080/14728222.2022.2035720] [Reference Citation Analysis]
7 Reddy D, Bhattacharya S, Shah S, Rashid M, Gupta S. DNA methylation mediated downregulation of histone H3 variant H3.3 affects cell proliferation contributing to the development of HCC. Biochim Biophys Acta Mol Basis Dis 2022;1868:166284. [PMID: 34626773 DOI: 10.1016/j.bbadis.2021.166284] [Reference Citation Analysis]
8 Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, da Silva TC, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. Cancers (Basel) 2021;13:5583. [PMID: 34771745 DOI: 10.3390/cancers13215583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Halasa M, Adamczuk K, Adamczuk G, Afshan S, Stepulak A, Cybulski M, Wawruszak A. Deacetylation of Transcription Factors in Carcinogenesis. Int J Mol Sci 2021;22:11810. [PMID: 34769241 DOI: 10.3390/ijms222111810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Silva-Gomez JA, Galicia-Moreno M, Sandoval-Rodriguez A, Miranda-Roblero HO, Lucano-Landeros S, Santos A, Monroy-Ramirez HC, Armendariz-Borunda J. Hepatocarcinogenesis Prevention by Pirfenidone Is PPARγ Mediated and Involves Modification of Nuclear NF-kB p65/p50 Ratio. Int J Mol Sci 2021;22:11360. [PMID: 34768791 DOI: 10.3390/ijms222111360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Garmpis N, Damaskos C, Garmpi A, Georgakopoulou VE, Sarantis P, Antoniou EA, Karamouzis MV, Nonni A, Schizas D, Diamantis E, Koustas E, Farmaki P, Syllaios A, Patsouras A, Kontzoglou K, Trakas N, Dimitroulis D. Histone Deacetylase Inhibitors in the Treatment of Hepatocellular Carcinoma: Current Evidence and Future Opportunities. J Pers Med 2021;11:223. [PMID: 33809844 DOI: 10.3390/jpm11030223] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
12 Afaloniati H, Poutahidis T, Giakoustidis A, Gargavanis A, Giakoustidis D, Angelopoulou K. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components. Mol Biol Rep 2021;48:551-62. [PMID: 33393006 DOI: 10.1007/s11033-020-06089-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]